نتائج البحث - Stefanie Mason

  • يعرض 1 - 5 نتائج من 5
تنقيح النتائج
  1. 1

    Author Correction: Proteomics and machine learning in the prediction and explanation of low pectoralis muscle area حسب Nicholas A. Enzer, Joe Chiles, Stefanie Mason, Toru Shirahata, Victor Castro, Elizabeth Regan, Bina Choi, Nancy F. Yuan, Alejandro A. Diaz, George R. Washko, Merry-Lynn McDonald, Raúl San José Estépar, Samuel Y. Ash, COPDGene Study Consortium

    الحاوية / القاعدة Scientific Reports (2025-03-01)
    احصل على النص الكامل
    مقال


  2. 2

    Proteomics and machine learning in the prediction and explanation of low pectoralis muscle area حسب Nicholas A. Enzer, Joe Chiles, Stefanie Mason, Toru Shirahata, Victor Castro, Elizabeth Regan, Bina Choi, Nancy F. Yuan, Alejandro A. Diaz, George R. Washko, Merry-Lynn McDonald, Raúl San José Estépar, Samuel Y. Ash, COPDGene Study Consortium

    الحاوية / القاعدة Scientific Reports (2024-08-01)
    احصل على النص الكامل
    مقال


  3. 3

    Immunologic investigations into transgene directed immune-mediated myositis following delandistrogene moxeparvovec gene therapy حسب Rachael A. Potter, Ida H. Moeller, Sohrab Khan, Hélène Haegel, Andreas Hollenstein, Guido Steiner, Christoph Wandel, Alexander P. Murphy, Damon R. Asher, Emanuel Palatinsky, Danielle A. Griffin, Stefanie Mason, Susan T. Iannaccone, Craig M. Zaidman, Louise R. Rodino-Klapac

    الحاوية / القاعدة Scientific Reports (2025-01-01)
    احصل على النص الكامل
    مقال


  4. 4

    O19: Integrated analyses of data from clinical trials of delandistrogene moxeparvovec gene therapy in DMD* حسب Erin O’Rourke, Crystal Proud, Craig Zaidman, Perry B. Shieh, Craig McDonald, John W. Day, Stefanie Mason, Maitea Guridi, Lixin Han, Lixi Yu, Carol Reid, Eddie Darton, Christoph Wandel, James Richardson, Jyoti Malhotra, Teji Singh, Louise Rodino-Klapac, Jerry Mendell

    الحاوية / القاعدة Genetics in Medicine Open (2023-01-01)
    احصل على النص الكامل
    مقال


  5. 5

    P314: Long-term safety and sustained functional benefit in patients with DMD 4 years post-treatment with delandistrogene moxeparvovec: A phase 1/2a study* حسب Erin O’Rourke, Jerry R. Mendell, Zarife Sahenk, Kelly J. Lehman, Linda P. Lowes, Natalie F. Reash, Megan Iammarino, Lindsay Alfano, Sarah Lewis, Kathleen Church, Richard Shell, Rachael A. Potter, Danielle Griffin, Mark J. Hogan, Shufang Wang, Stefanie Mason, Eddie Darton, Louise Rodino-Klapac

    الحاوية / القاعدة Genetics in Medicine Open (2023-01-01)
    احصل على النص الكامل
    مقال


أدوات البحث: